Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesClinical/Medical PolicyBCBSRI Category III CPT Coverage & Prior Auth | Op…
    Ask Trek AI about this page
    DraftBlue Cross Blue Shield - Rhode IslandPolicy N/A

    New Technology and Miscellaneous Services (Category III CPT® Codes)

    Customize your policy alerts

    Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts

    Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines BCBSRI coverage categories and prior authorization rules for CPT codes representing new and emerging technologies (primarily Category III codes) for Medicare Advantage and Commercial products.

    Policy Summary
    PayerBlue Cross Blue Shield - Rhode Island
    PolicyNew Technology and Miscellaneous Services (Category III CPT® Codes)
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateOct 1, 2026
    Last ReviewJan 10, 2026
    Next Review DateJan 4, 2026
    Key ActionObtain prior authorization when indicated in the Code and Coverage Grid; Fully-Funded Commercial requests from specified contracted PCPs may be exempt (effective 10/1/2025).
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    Category IIIprimary code type covered
    PCP exemptionPrior auth exemption
    Multiplecoverage categories
    Semi-annualCPT update cadence

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Coverage Criteria for New and Emerging Technology Codes

    Coverage categories for new and emerging technology codes

    BCBSRI uses category-based coverage determinations for new and emerging procedure codes; benefits vary by product and contract.

    Coverage categories: Available coverage categories include: Covered; Not Covered (evidence insufficient); Preauthorization is required; Not separately reimbursed; Use alternate procedure code. For Commercial Products additional categories include: Not Covered and a contract exclusion; Not medically necessary (evidence insufficient); Preauthorization is recommended.

    Applies differently to Medicare Advantage and Commercial Products as described in policy.

    Medical necessity definition

    Medically necessary criteria

    Medically necessary items and services: Items and services must be consistent with the symptoms/diagnosis of the illness or injury; necessary for and consistent with generally accepted professional medical standards of care (i.e., not experimental); not furnished primarily for the convenience of the patient or provider; and furnished at the most appropriate level of care that can be provided safely and effectively to the patient.

    If prevailing expert opinion is that more studies or clinical trials are necessary to determine safety, efficacy, toxicity, or comparative efficacy, the treatment or procedure is considered not medically necessary.

    Device investigational policy

    Medicare Advantage device coverage stance

    FDA device categories: Category A (Experimental) devices are considered not medically reasonable and necessary and are not covered. Category A refers to device types for which absolute risk has not been established (initial safety/effectiveness questions unresolved). Category B (Non-experimental/investigational) devices may be covered if they are considered medically reasonable and necessary and all other applicable Medicare coverage requirements are met.

    Applies to Medicare Advantage Plans.

    Benefits for services described in this policy may vary by group or contract. Providers and staff should always consult the member’s governing benefit documents — the Benefit Booklet, Evidence of Coverage, or Subscriber Agreement — to confirm whether a particular service is covered or excluded for that member.

    A service is considered medically necessary only when it meets all of the following: it is consistent with the patient’s symptoms and diagnosis; it is necessary for and consistent with generally accepted professional medical standards of care (that is, not experimental); it is not primarily for the convenience of the patient or provider; and it is furnished at the most appropriate level of care to provide safe and effective treatment.

    The policy defines a treatment or procedure as not medically necessary when reliable evidence demonstrates that prevailing expert opinion requires additional studies or clinical trials to determine safety, efficacy, toxicity, maximum tolerated dose, or comparative effectiveness. For Medicare Advantage plans, devices categorized by the FDA as Category A (Experimental) are considered not medically reasonable and necessary and are not covered; Category B devices may be covered if otherwise medically reasonable and all Medicare requirements are met.

    Codes, Grids, and Archival Rules

    See attached Code and Coverage Gridmixed
    No codes listed
    Category III archival timeframe
    Archival timeframeCategory III codes are generally archived five years from the date of initial publication or extension unless the archival date is specifically modified at the time of a revision or code change.
    Reporting after archivingServices described by archived Category III codes (without conversion to Category I) must be reported using a Category I unlisted code unless a specific cross-reference is established at archiving.
    Update cadenceNew or revised Category III codes are released semi-annually via the AMA CPT® website.
    Use instead of unlistedIf a Category III code is available, it must be reported instead of a Category I unlisted code to allow collection of specific data.

    Provider Requirements, Prior Authorization, and Documentation

    Prior Authorization

    Prior authorization required; PCP exemption for Fully‑Funded Commercials

    Prior authorization is required for services when the Code and Coverage Grid in the Coding section indicates prior authorization is needed. Effective 10/1/2025, Fully-Funded Commercial Products may not require prior authorization when the requesting physician is a BCBSRI-contracted primary care provider in the listed specialties; prior authorization remains required for all other Commercial Products (including Self-Funded) and Medicare Advantage Plans.

    • See the Coding section's Code and Coverage Grid for which services require prior authorization.
    • Exemption (effective 10/1/2025) applies only to Fully-Funded Commercial Products and only when the requesting physician is a BCBSRI-contracted PCP in the listed specialties.
    Note

    Follow Code & Coverage Grid and Related Policies for prior authorization

    When prior authorization is required, providers must follow the Related Policies identified in the Code and Coverage Grid in the Coding section for the applicable medical criteria. For Fully‑Funded Commercial Products the policy confirms the PCP exemption applies as specified in the Coding/prior authorization guidance.

    Background on Category III CPT® Codes

    Category III CPT® codes are temporary codes established to report emerging technologies, services, and procedures primarily to support data collection on utilization and outcomes. Their presence in coding does not, by itself, indicate established clinical benefit or guarantee coverage.

    Category III codes are intended to identify and monitor new or evolving services and may be archived after a period (commonly five years from initial publication unless extended). Where a Category III code exists for a service, it should be used in place of a Category I unlisted code to ensure accurate tracking and data collection.

    Key Definitions

    Category III codes definition
    PurposeTemporary CPT® codes for emerging technologies, services, and procedures used to collect utilization and outcomes data and to identify emerging technologies for efficacy and monitoring.
    Data collection needCategory III codes allow physicians, insurers, and researchers to collect specific data that unlisted codes do not provide.
    No implication of coverageInclusion of a service in Category III does not imply clinical efficacy, safety, or payer coverage.
    Substitution ruleWhere a Category III code exists it must be used instead of a Category I unlisted code.
    Medically necessary definition
    Core criteriaItems and services must be consistent with the symptoms/diagnosis, necessary and consistent with generally accepted professional medical standards (not experimental), not primarily for convenience, and furnished at the most appropriate level of care.
    Policy Summary
    PayerBlue Cross Blue Shield - Rhode Island
    PolicyNew Technology and Miscellaneous Services (Category III CPT® Codes)
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateOct 1, 2026
    Last ReviewJan 10, 2026
    Next Review DateJan 4, 2026
    Key ActionObtain prior authorization when indicated in the Code and Coverage Grid; Fully-Funded Commercial requests from specified contracted PCPs may be exempt (effective 10/1/2025).
    SourceLink
    On This Page
    Coverage Criteria for New and Emerging Technology CodesCodes, Grids, and Archival RulesProvider Requirements, Prior Authorization, and DocumentationBackground on Category III CPT® CodesKey Definitions
    • Follow the Related Policies listed in the Code and Coverage Grid for documentation and medical necessity criteria.
    • Confirm whether the requesting provider meets the BCBSRI-contracted PCP specialties list to determine if the Fully‑Funded Commercial exemption applies.
    Documentation Required

    Documentation sources: Related Policies in the Coding grid

    For services that require prior authorization, providers must refer to the Related Policies identified in the Code and Coverage Grid in the Coding section for the appropriate medical criteria; the Coding section (attached grid) indicates coverage and prior authorization expectations.

    • Use the Coding section's attached grid to identify required Related Policies and medical criteria.
    • Ensure documentation submitted with authorization requests aligns with the Related Policies referenced in the grid.
    Denial Risk

    Denial risk if prior authorization not obtained; limited PCP exemption

    Requests for services may be denied if prior authorization is required and not obtained. The Fully‑Funded Commercial PCP exemption (effective 10/1/2025) may reduce denials for those specific requests; prior authorization remains required for other Commercial Products and Medicare Advantage Plans.

    • If prior authorization is indicated in the Code and Coverage Grid and was not obtained, the request may be denied.
    • The PCP exemption applies only to Fully‑Funded Commercial Products when the requesting clinician is a BCBSRI‑contracted PCP in the specified specialties.
    Not medically necessary thresholdA treatment or procedure is considered not medically necessary if prevailing expert opinion indicates more studies or clinical trials are needed to determine safety, efficacy, toxicity, maximum tolerated dose, or comparative efficacy.
    Relation to evidenceMedically necessary determinations require that items and services be established as safe and effective.
    FDA Category A (Experimental) device definition
    DefinitionFDA Category A (Experimental) device refers to a device type for which 'absolute risk' has not been established; initial safety and effectiveness questions remain unresolved.
    Coverage stance for MACategory A devices are considered not medically reasonable and necessary for Medicare Advantage Plans and are therefore not covered.
    Risk implicationIndicates that the FDA is unsure whether the device type can be safe and effective.
    FDA Category B (Non-experimental/investigational) device definition
    DefinitionFDA Category B (Non-experimental/investigational) device refers to a device type for which the incremental risk is the primary question, meaning initial safety/effectiveness questions for the device type have been resolved.
    Coverage stance for MACategory B devices may be covered for Medicare Advantage Plans if considered medically reasonable and necessary and all other applicable Medicare coverage requirements are met.
    Evidence basisMay be known to be safe and effective because other manufacturers have obtained FDA premarket approval or clearance for that device type.